STAT1 and fibrosarcoma: To test whether STAT2 interferes with STAT1 DNA binding, we used electrophoretic mobility shift assays (EMSAs) with extracts from STAT2-deficient human U6A fibrosarcoma cells and stable derivatives expressing WT STAT2 or mutant STAT2-L82A (Fig 2D, S5 Fig).